GME_18x18.jpg
Global Cell & Gene Therapy Manufacturing Market Analysis
03 janv. 2023 07h35 HE | Global Market Estimates
Brooklyn, New York, Jan. 03, 2023 (GLOBE NEWSWIRE) -- According to a new market research report published by Global Market Estimates, the Global Cell & Gene Therapy Manufacturing Market is...
alphageneronlogo.jpg
Alphageneron to Participate in Cell Therapy Durability Response Summit
17 août 2022 10h30 HE | Alphageneron Pharmaceuticals
CAMBRIDGE, Mass., Aug. 17, 2022 (GLOBE NEWSWIRE) -- Alphageneron Pharmaceuticals, Inc. (“Alphageneron” or the “Company”), a clinical stage pharmaceutical company developing a diverse platform of...
GME_18x18.jpg
Global Cell & Gene Therapy Raw Material Testing Market Size
04 juil. 2022 08h07 HE | Global Market Estimates
Brooklyn, New York, July 04, 2022 (GLOBE NEWSWIRE) -- According to a new market research report published by Global Market Estimates, the Global Cell & Gene Therapy Raw Material Testing Market...
Sm-logo-resized.jpg.png
Recombinant Protein Market worth $3.93 Billion by 2030, Registering a CAGR of 10.12%
03 juin 2022 08h59 HE | STRATEGIC MARKET RESEARCH LLP
New York, United States, June 03, 2022 (GLOBE NEWSWIRE) -- Recombinant protein is regarded as a manipulated form of the native protein, which is generated in a variety of ways in order to increase...
new-pharma300x111.jpg
Informa Pharma Intelligence and The American Society of Gene & Cell Therapy (ASGCT) Launches Gene, Cell & RNA Therapy Landscape Q1 2022 Quarterly Data Report
28 avr. 2022 12h00 HE | Informa Business Intelligence
NEW YORK, April 28, 2022 (GLOBE NEWSWIRE) -- Informa Pharma Intelligence, the global business intelligence provider for the biopharma industry, and The American Society of Gene & Cell Therapy...
alphageneronlogo.jpg
Alphageneron to Participate in the ROTH Virtual Healthcare Private Company Forum on June 28th, 2021
25 juin 2021 19h21 HE | Alphageneron Pharmaceuticals
CAMBRIDGE, Mass., June 25, 2021 (GLOBE NEWSWIRE) -- Alphageneron Pharmaceuticals, Inc. (“Alphageneron” or the “Company”), a privately-held clinical-stage biopharmaceutical company developing...
Alliance Reg Med.png
The Alliance for Regenerative Medicine Releases Q3 2019 Sector Report, Highlighting Industry Trends and Metrics
05 nov. 2019 11h03 HE | Alliance for Regenerative Medicine
WASHINGTON, D.C., Nov. 05, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- The Alliance for Regenerative Medicine (ARM) today released its most recent quarterly sector report, offering an in-depth look...
Alliance Reg Med.png
The Alliance for Regenerative Medicine Announces Initial Slate of Presenting Companies at the Seventh Annual Cell & Gene Therapy Investor Day
07 févr. 2019 12h21 HE | Alliance for Regenerative Medicine
WASHINGTON, D.C., Feb. 07, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- The Alliance for Regenerative Medicine (ARM) today announced the initial slate of presenting companies at its annual Cell...